CHICAGO, July 10, 2012 /PRNewswire/ -- Bankers Life and Casualty Company today announced a new addition to its portfolio of life and health insurance products, Critical Benefit(SM).
Critical Benefit is critical illness insurance that pays a lump-sum benefit when an insured person is diagnosed with a specified critical illness. It's designed to provide additional financial protection associated with treatment and recovery as well as cover non-medical expenses, such as:
- Loss of income
- At home recovery or treatment
- Experimental and or alternative medicine
- Co-pays, deductibles and out-of-network expenses
- Child care and transportation costs
With the ever-rising, high-deductible health plans and the gaps in the insurance coverage carried by most middle-income Americans, critical illness insurance can provide valuable financial protection after a critical diagnosis."The risk of a critical illness is real," said Chris Campbell, vice president of strategic marketing and business development for Bankers Life and Casualty Company. "According to the American Cancer Society, one in two men and one in three women will develop cancer in their lifetime and per the American Heart Association, every 40 seconds, someone in the United States will suffer a stroke. Policies like Critical Benefit can help alleviate the financial burden and stress that can come from the unexpected costs associated with treatment and recovery of a common catastrophic illness." Critical Benefit is available for people age 18 to 85 and offers three policy options:
- Cancer only coverage pays the full lump-sum cash benefit if diagnosed with cancer.
- Heart attack, stroke and end-stage renal failure coverage pays the full lump-sum cash benefit when one critical illness is diagnosed.
- Combination coverage pays a cash benefit when cancer, heart attack, stroke or end-stage renal failure is diagnosed.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV